Delivery Order SPE2DB22D3301-SPE2DB25FY6VM
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a ceiling value of $10,947.00. The contract is a firm fixed-price delivery order, with an ultimate completion date of July 28, 2025. This contract is not designated as a set-aside and is open to full and open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products. The contract has a firm fixed-price pricing type and a ceiling value of $36,490.00. The period of performance extends until May 29, 2025. This delivery order is placed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $3,649.00. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $18,245.00. The contract is a firm fixed price delivery order, with a period of performance extending through June 4, 2025. The contract has no set-aside designation, indicating open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $18,245.00. The contract has an ultimate completion date of August 5, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.50, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 21, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML. The contract has a ceiling value of $7,298.00 and runs through January 3, 2025. The contract was awarded on December 11, 2024 and uses a firm fixed price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award is a Delivery Order with a Firm Fixed Price contract type, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product, with a Ceiling Value of $14,108.80 and an Ultimate Completion Date of October 2, 2024. The contract is not set aside and represents an open competition. AmerisourceBergen Drug...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,947.00, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $18,245.00 and a performance period ending on May 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY6VMDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a ceiling value of $14,596.00. The contract is a firm fixed-price delivery order with a period of performance through July 17, 2025. The contract is not set-aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 6/25/25 |